Ukr.Biochem.J. 2013; Volume 85, Issue 5, Sep-Oct, pp. 105-113


Peculiarities of arginase and NO-synthase pathways of L-arginine metabolism in peripheral blood lymphocytes of patients with ovarian cancer

O. I. Yakubets, R. V. Fafula, D. Z. Vorobets, Z. D. Vorobets

Danylo Halytski Lviv National Medical University, Ukraine;

The peculiarities of arginase and NO-synthase pathways of L-arginine metabolism in peripheral blood lymphocytes of patients with ovarian cancer were studied. It was shown that the development of cancer pathology is associated with an imbalance in the NO synthesis in blood lymphocytes. The reason for such imbalance is the activation of arginase and inducible isoform of NO-synthase (iNOS) and significant inhibition of its constitutive isoform. The analysis of the kinetic properties of NOS of blood lymphocytes of patients with ovarian cancer was carried out. It was shown that the affinity constant of iNOS affinity for L-arginine is 5.4-fold lower than for eNOS of blood lymphocytes of persons in the control group. The inhibition of eNOS occurs via non-competitive type and is related to the reduction of maximum reaction rate.

Keywords: , , , , ,


  1. Fukuzawa K., Kogure K., Morita M., Hama S., Manabe S., Tokumura A. Enhancement of nitric oxide and superoxide generation by α-tocopheryl succinate and its apoptotic and anti-cancer effects. Biochemistry (Mosc.). 2004 Jan;69(1):50-7. PubMed, CrossRef
  2. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006 Jul;6(7):521-34. Review. PubMedCrossRef
  3. Karimov KhIa, Inoiatova FKh, Mukhamedova MT. Changes in some parameters of nitric oxide synthesis in the early periods of development of hepatocarcinogenesis. Lik Sprava. 2002;(7):90-2. Russian. PubMed
  4. Reutov VP. Review: nitric oxide cycle in mammals and the cyclicity principle. Biochemistry (Mosc.). 2002 Mar;67(3):353-376. PubMed, CrossRef
  5. Lyu MB, Podobed IS, Edygenova AK, Lyu BN.  Active oxygen forms and peroxigenesis in invasion and metastasis of neoplasms.  Usp Sovrem Biol. 2004;124(4):329-341.
  6. Hofseth LJ, Hussain SP, Wogan GN, Harris CC. Nitric oxide in cancer and chemoprevention. Free Radic Biol Med. 2003 Apr 15;34(8):955-68. Review. PubMedCrossRef
  7. Crowell JA, Steele VE, Sigman CC, Fay JR. Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther. 2003 Aug;2(8):815-23. Review. PubMed
  8. Stepanov YM, Kononov IN, Zhurbina AI, Filippova AY. Arginine in medical practice. Zhurn Akad Med Nauk Ukrainy. 2004;10(1):340-352.
  9. Brodiak IV, Sybirna NO.Peculiarities of L-arginine metabolism in the blood leukocytes in experimental diabetes mellitus. Fiziol Zhurn. 2008;54(1):63-8. Ukrainian. PubMed
  10. Cancer in Ukraine, 2009-2010.  Morbidity, mortality, and performance of the oncological service. Bull Nat Cancer Registry Ukraine. 2011;(12):61-62.
  11. Mikhanovsky A. A., Slobodianiuk O. V.  Contemporary aspects of diagnosis and treatment for ovarian cancer. Int Med J. 2012;18(2):85-89.
  12. Buchinska LG, Nesina IP, Tkachenko NI, Polischuk LZ. Peculiarities of peripheral blood lymphocyte nucleoli in patients with corpus uteri cancer. Onkologya. 2002;4(1):18-20.
  13. Lugovskoy SP. Changes in the activity of the enzyme spectrum of peripheral blood lymphocytes upon lead intoxication (cytochemical study). Lab Diagnost. 2002;(2):29-32.
  14. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77-89. PubMed
  15. Fafula R, Efremova U, Lychkovska N, Melnyk O, Vorobets Z, Kulachkovskiy O. Methodological Approaches to the Study of Enzymatic Spectrum of Lymphocytes at Patological States with the Application of Saponin (ultrastructure research). Visnyk Probl Biol Med. 2012;1(4):163-166.
  16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265-75. PubMed
  17. Ochoa JB, Bernard AC, O’Brien WE, Griffen MM, Maley ME, Rockich AK, Tsuei BJ, Boulanger BR, Kearney PA, Morris Jr SM Jr. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg. 2001 Mar;233(3):393-9. PubMed, PubMedCentral, CrossRef
  18.  Sybirna NO, Maevska OM, Barska ML. Investigation of some biochemical parameters under oxidative stress condition. Lviv: Vydav. Centr Ivana Franka; 2006. 60p.
  19. Kosterin SA, Burchinskaia NF. A method for determining the kinetic characteristics of Ca2+-transporting systems of subcellular structures in smooth muscle.  Ukr Biokhim Zhurn. 1987 Mar-Apr;59(2):66-9. Russian. PubMed
  20. Keleti T. Foundations of enzyme kinetics. Moscow: Mir, 1990. 350 p.
  21. Saluja R, Jyoti A, Chatterjee M, Habib S, Verma A, Mitra K, Barthwal MK, Bajpai VK, Dikshit M. Molecular and biochemical characterization of nitric oxide synthase isoforms and their intracellular distribution in human peripheral blood mononuclear cells. Biochim Biophys Acta. 2011 Oct;1813(10):1700-7. PubMed, CrossRef
  22. Ridnour LA, Thomas DD, Donzelli S, Espey MG, Roberts DD, Wink DA, Isenberg JS. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Signal. 2006 Jul-Aug;8(7-8):1329-37. Review. PubMed, CrossRef
  23. Nomelini RS, de Abreu Ribeiro LC, Tavares-Murta BM, Adad SJ, Murta EF. Production of nitric oxide and expression of inducible nitric oxide synthase in ovarian cystic tumors. Mediators Inflamm. 2008;2008:186584. PubMed, PubMedCentral, CrossRef
  24. Malone JM, Saed GM, Diamond MP, Sokol RJ, Munkarah AR. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer. Am J Obstet Gynecol. 2006 Apr;194(4):1110-6; discussion 1116-8. PubMed, CrossRef
  25. Chen T, Nines RG, Peschke SM, Kresty LA, Stoner GD. Chemopreventive effects of a selective nitric oxide synthase inhibitor on carcinogen-induced rat esophageal tumorigenesis. Cancer Res. 2004 May 15;64(10):3714-7. PubMed, CrossRef
  26. Melichar B, Hu W, Patenia R, Melicharová K, Gallardo ST, Freedman R. rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition. J Transl Med. 2003 Sep 19;1(1):5. PubMed, PubMedCentral, CrossRef
  27. Polat MF, Taysi S, Polat S, Böyük A, Bakan E. Elevated serum arginase activity levels in patients with breast cancer. Surg Today. 2003;33(9):655-61. PubMed, CrossRef
  28. Arzamastsev AP, Severina IS, Grigor’ev NB, Granik VG. Exogenous donors of nitric oxide and inhibitors of NO-synthase (chemical aspects).  Vestn Ross Akad Med Nauk. 2003;(12):88-95. Review. Russian.  PubMed
  29. Kratenko RI. Influence of ionizing radiation and 12-crown-4 on L-arginine-dependent synthesis of nitrogen oxide and NO-synthase activity. Ukr J Radiol. 2006;14(3):264-267.
  30. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA. 1995 May 9;92(10):4392-6. PubMed, PubMed, CrossRef
  31. Morris SM. Enzymes of Arginine Metabolism. J Nutr. 2004 Oct;134(10 Suppl):2743S-2747S. PubMed
  32. Blachier F, Mignon A, Soubrane O. Polyamines inhibit lipopolysaccharide-induced nitric oxide synthase activity in rat liver cytosol. Nitric Oxide. 1997 Jun;1(3):268-72. PubMed, CrossRef
  33. Mori M, Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun. 2000 Sep 7;275(3):715-9. Review. PubMed, CrossRef
  34. Popovic PJ, Zeh HJ 3rd, Ochoa JB. Arginine and immunity. J Nutr. 2007 Jun;137(6 Suppl 2):1681S-1686S. Review. PubMed
  35. Morris SM Jr. Arginine: beyond protein. Am J Clin Nutr. 2006 Feb;83(2):508S-512S. Review. PubMed
  36. Vanin AF. Nitrogen oxide: regulation of the cell metabolism without involvement of the cellular receptor system. Biofizika. 2001 Jul-Aug;46(4):631-41. Russian. PubMed
  37. Glazev A, Smirnov V, Karavay A, Doroshenko E, Nefyodov L. Characteristics of changes of the amino acid pool of plasma blood in solid malignant growth under influence of thiophosphoric derivatives of alkaloids of Cheliodonium majus L. Proc Belar State Univ.  2007;2(1):131-139.
  38. Grigoryan RS, Panosyan EH, Seibel NL, Gaynon PS, Avramis IA, Avramis VI. Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961). In Vivo. 2004 Mar-Apr;18(2):107-12. PubMed
  39. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998 Nov 15;336(Pt 1):1-17.  PubMed, PubMedCentral, CrossRef
  40. Scott L, Lamb J, Smith S, Wheatley DN. Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br J Cancer. 2000 Sep;83(6):800-10. PubMed, PubMedCentral, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.